The Review on Antimicrobial Resistance, The Wellcome Trust and the UK Government
Chaired by Jim O’Neill, December 2014
The authors demonstrate that there could be profound health and macroeconomic consequences for the world, especially in emerging economies, if antimicrobial resistance (AMR) is not tackled. They believe that this crisis can be avoided. The cost of taking action can be small if we take the right steps soon. And the benefits will be large and long-lasting especially for emerging economies, including the so-called BRIC nations, who will need to make improved investments in their health infrastructure and build industries that leapfrog to the next generation of innovation.